Grous Beth
Chief People Officer
Grous Beth has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 2, 2026.
On the most recent filing, Grous Beth is listed as Chief People Officer at Generate Biomedicines, Inc. Inside the rolling window, Grous Beth reported 1 open-market purchase totaling $5K in GENB and no open-market sales.
Companies traded
Other insiders at GENB
Insider Buying
$5K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Grous Beth made?
Grous Beth has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Grous Beth trade?
Grous Beth has filed SEC Form 4 disclosures for 1 company, including GENB.
When was Grous Beth's most recent SEC Form 4 filing?
Grous Beth's most recent SEC Form 4 filing on Tracefour is dated Mar 2, 2026.
What is Grous Beth's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Grous Beth is listed as Chief People Officer.
What is Grous Beth's total buy and sell value in the current window?
Inside the rolling retention window, Grous Beth bought $5K and sold $0 based on SEC Form 4 filings.
What was Grous Beth's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 300 GENB shares on 2026-03-02, worth $5K, per SEC Form 4 filings.